Vanguard Group Inc Roivant Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 44,087,287 shares of ROIV stock, worth $459 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,087,287
Previous 41,683,055
5.77%
Holding current value
$459 Million
Previous $481 Million
8.43%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$686 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$647 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$498 Million1.91% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$361 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.34B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...